{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:12:18Z","timestamp":1753891938405,"version":"3.41.2"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T00:00:00Z","timestamp":1634169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate the efficacy of clinical triage of oncological patients for safe continuation of cancer therapy implemented during the first SARS-CoV-2 outbreak.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Between 25 February and 21 April 2020, patients attending the Medical Oncology Unit, Spedali Civili Hospital, Brescia (Italy) for cancer therapy underwent triage to identify those with no signs and symptoms suspicious for SARS-CoV-2 infection in which antineoplastic treatment could be continued as scheduled. Triage questions investigated common symptoms (e.g., fever, cough, dyspnea, anosmia, dysgeusia, headache, nasal congestion, conjunctival congestion, sore throat, diarrhea, nausea and vomiting); body temperature and pulse oximetry were also recorded. All patients were followed-up for overt SARS-CoV-2 through to 18<jats:sup>th<\/jats:sup> May 2020.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, 1180 patients (median age 65 years) underwent triage during the study period. The most frequent primary malignances were breast (32%), gastrointestinal (18%), and lung (16.5%) cancer. Thirty-one (2.5%) presented with clinically evident SARS-CoV-2 infection and tested positive on nasopharyngeal swab testing and\/or radiological imaging. Triage identified 69 (6%) grey zone patients with symptoms suspicious for SARS-CoV-2; 5 (7.2%) subsequently developed symptomatic disease. Neither the symptomatic nor the grey zone patients received their scheduled treatment; instead, they were referred for hospitalization or home quarantine.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Triage of oncological patients at our Unit provided for safe continuation of scheduled cancer treatment in 91.5% of patients during the initial SARS-CoV-2 outbreak.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2021.707346","type":"journal-article","created":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T09:36:37Z","timestamp":1634204197000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic"],"prefix":"10.3389","volume":"11","author":[{"given":"Cristina","family":"Gurizzan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Pedersini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Fornaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Sardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Zamparini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Monteverdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Tovazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Cosentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Dalla Volta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Baggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Turla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"Di Mauro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Lorini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Lagan\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Grisanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Consoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Conti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Berruti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus\u2013Infected Pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1002\/lary.28692","article-title":"Anosmia and Ageusia: Common Findings in COVID-19 Patients","volume":"130","author":"Vaira","year":"2020","journal-title":"Laryngoscope"},{"key":"B4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical Features of Patients Infected With 2019 Novel Coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70069-5","article-title":"Nosocomial Infections in Patients With Cancer","volume":"10","author":"Kamboj","year":"2009","journal-title":"Lancet Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/286170","article-title":"Selective Depletion of Regulatory T Cell Subsets by Docetaxel Treatment in Patients With Nonsmall Cell Lung Cancer","volume":"2014","author":"Li","year":"2014","journal-title":"J Immunol Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000001484","article-title":"Features of Postoperative Immune Suppression Are Reversible With Interferon Gamma and Independent of Interleukin-6 Pathways","volume":"264","author":"Longbottom","year":"2016","journal-title":"Ann Surg"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2017.07.010","article-title":"Myeloid Suppressor Cells in Cancer and Autoimmunity","volume":"85","author":"Sica","year":"2017","journal-title":"J Autoimmun"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer Patients in SARS-CoV-2 Infection: A Nationwide Analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30310-7","article-title":"Clinical Characteristics, Outcomes, and Risk Factors for Mortality in Patients With Cancer and COVID-19 in Hubei, China: A Multicentre, Retrospective, Cohort Study","volume":"21","author":"Yang","year":"2020","journal-title":"Lancet Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31187-9","article-title":"Clinical Impact of COVID-19 on Patients With Cancer (CCC19): A Cohort Study","volume":"395","author":"Kuderer","year":"2020","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31173-9","article-title":"COVID-19 Mortality in Patients With Cancer on Chemotherapy or Other Anticancer Treatments: A Prospective Cohort Study","volume":"395","author":"Lee","year":"2020","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01307","article-title":"Chemotherapy and COVID-19 Outcomes in Patients With Cancer","volume":"38","author":"Jee","year":"2020","journal-title":"J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.7560","article-title":"Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal","volume":"18","author":"Ueda","year":"2020","journal-title":"J Natl Compr Cancer Netw"},{"unstructured":"ESMO COVID-19 and Cancer","key":"B15"},{"unstructured":"NCCN Coronavirus Disease 2019 (COVID-19) Resources for the Cancer Care Community","key":"B16"},{"unstructured":"ASCO Coronavirus Resources","key":"B17"},{"unstructured":"AIOM","key":"B18"},{"unstructured":"Pandemic Planning Clinical Guideline for Patients With Cancer2020","key":"B19"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13706","article-title":"Feasibility and Predictive Performance of a Triage System for Patients With Cancer During the COVID -19 Pandemic","volume":"26","author":"Fasola","year":"2021","journal-title":"Oncologist"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33366","article-title":"Triage Process for the Assessment of Coronavirus Disease 2019-Positive Patients With Cancer: The ONCOVID Prospective Study","volume":"127","author":"Indini","year":"2021","journal-title":"Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01574","article-title":"The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures","volume":"10","author":"Dalla Volta","year":"2020","journal-title":"Front Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082237","article-title":"Cancer Management During COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial","volume":"12","author":"Vivarelli","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.652535","article-title":"COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway","volume":"11","author":"Johannesen","year":"2021","journal-title":"Front Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13768","article-title":"Risk of COVID -19 in Patients With Cancer Receiving Immune Checkpoint Inhibitors","volume":"26","author":"Klebanov","year":"2021","journal-title":"Oncologist"},{"key":"B26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.breast.2020.04.006","article-title":"Recommendations for Triage, Prioritization and Treatment of Breast Cancer Patients During the COVID-19 Pandemic","volume":"52","author":"Curigliano","year":"2020","journal-title":"Breast"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e000885","DOI":"10.1136\/esmoopen-2020-000885","article-title":"Optimising Triage Procedures for Patients With Cancer Needing Active Anticancer Treatment in the COVID-19 Era","volume":"5","author":"Arpino","year":"2020","journal-title":"ESMO Open"},{"key":"B28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3892\/ijmm.2021.4933","article-title":"Current and Innovative Methods for the Diagnosis of COVID\u221219 Infection (Review)","volume":"47","author":"Falzone","year":"2021","journal-title":"Int J Mol Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1200\/GO.20.00603","article-title":"OncoAlert Round Table Discussions: The Global COVID-19 Experience","volume":"7","author":"Morgan","year":"2021","journal-title":"JCO Glob Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.593491","article-title":"Sensitivity of SARS-CoV-2 Detection With Nasopharyngeal Swabs","volume":"8","author":"Clerici","year":"2021","journal-title":"Front Public Heal"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.707346\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T09:38:32Z","timestamp":1634204312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.707346\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,14]]},"references-count":30,"alternative-id":["10.3389\/fonc.2021.707346"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.707346","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2021,10,14]]},"article-number":"707346"}}